Preparation of V3-V6-Fc- and Fab-and/or F(ab)2-modified purified material, control material, and characterization data

SOL #: 13013769616Special NoticeSole Source

Overview

Buyer

Dept Of Defense
Dept Of The Navy
NAVAL MEDICAL RESEARCH CENTER
SILVER SPRING, MD, 20910-7500, United States

Place of Performance

Silver Spring, MD

NAICS

No NAICS code specified

PSC

General Science And Technology R&D Services; General Science And Technology; Applied Research (AJ12)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 8, 2026
2
Action Date
Jun 12, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Naval Medical Research Command (NMRC), under the Department of the Navy, has issued a Special Notice indicating its intent to award a contract to Poly Solutions for specialized biomaterial preparation and characterization services. This requirement, procured on an other than full and open competition basis, seeks to prepare V3-V6-Fc- and Fab-and/or F(ab)2-modified purified material and control material, along with generating characterization data. The primary objective is to develop V3-V6 modified material with reduced or no ability to cause Antibody-Dependent Enhancement (ADE). Capability statements from interested parties will be considered, with a response deadline of June 12, 2026.

Scope of Work

The required services involve:

  • Preparation of V3-V6-Fc- and Fab-and/or F(ab)2-modified purified material.
  • Preparation of control material.
  • Generation of comprehensive characterization data for each material.
  • All materials are to be prepared from NMRC crude (neat) Tc-bovine plasma.
  • The ultimate goal is to produce V3-V6 modified material that minimizes or eliminates Antibody-Dependent Enhancement (ADE).

Contract Details

  • Opportunity Type: Special Notice (Intent to Award)
  • Procurement Basis: Other than full and open competition (brand name equipment)
  • Proposed Contractor: Poly Solutions, Sioux Falls, SD
  • NAICS Code: 541714 (Research and Development in Biotechnology)
  • Product Service Code (PSC): AJ12 (General Science And Technology R&D Services; Applied Research)
  • Procurement Guidelines: FAR Part 12 Commercial Items
  • Set-Aside: None specified
  • Place of Performance: Silver Spring, MD

Response Information

  • Response Due Date: June 12, 2026, at 7:00 PM ET
  • Published Date: June 8, 2026
  • Submission: This notice is not a request for competitive proposals; however, the Government will consider capability statements from interested parties.
  • Registration: Contractors must be registered in the System for Award Management (SAM) and possess a Unique Entity Identification (UEI) number to be eligible for any potential award.

Contact Information

People

Points of Contact

Shamai CarterPRIMARY
Nataki JOHNSONSECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: Jun 8, 2026
Preparation of V3-V6-Fc- and Fab-and/or F(ab)2-modified purified material, control material, and characterization data | GovScope